Cancers | Free Full-Text | Drug Resistance in Colorectal Cancer: From Mechanism to Clinic
Uncommon EGFR mutations in non-small-cell lung cancer: A systematic literature review of prevalence and clinical outcomes - ScienceDirect
The epidermal growth factor receptor variant III (EGFRvIII): where wild things are altered - Gan - 2013 - The FEBS Journal - Wiley Online Library
Cetuximab–Polymersome–Mertansine Nanodrug for Potent and Targeted Therapy of EGFR-Positive Cancers | Biomacromolecules
Development of Dual Inhibitors Targeting Epidermal Growth Factor Receptor in Cancer Therapy | Journal of Medicinal Chemistry
Kidney function trajectory in BBS subjects. (A) eGFR declines with age... | Download Scientific Diagram
Beyond EGFR inhibition: multilateral combat strategies to stop the progression of head and neck cancer | Experimental & Molecular Medicine
IJMS | Free Full-Text | The Therapeutic Potential of the Restoration of the p53 Protein Family Members in the EGFR-Mutated Lung Cancer
EGFR targeting for cancer therapy: Pharmacology and immunoconjugates with drugs and nanoparticles - ScienceDirect
The epidermal growth factor receptor variant III (EGFRvIII): where wild things are altered - Gan - 2013 - The FEBS Journal - Wiley Online Library
Promotion or remission: a role of noncoding RNAs in colorectal cancer resistance to anti-EGFR therapy | Cell Communication and Signaling | Full Text
Understanding resistance to EGFR inhibitors—impact on future treatment strategies | Nature Reviews Clinical Oncology
Full article: Synthesis, characterization and preliminary biological evaluation of chrysin amino acid derivatives that induce apoptosis and EGFR downregulation
Beyond EGFR inhibition: multilateral combat strategies to stop the progression of head and neck cancer | Experimental & Molecular Medicine
Promotion or remission: a role of noncoding RNAs in colorectal cancer resistance to anti-EGFR therapy | Cell Communication and Signaling | Full Text
ERBB receptors and cancer: the complexity of targeted inhibitors | Nature Reviews Cancer
Frontiers | EGFR/FOXO3A/LXR-α Axis Promotes Prostate Cancer Proliferation and Metastasis and Dual-Targeting LXR-α/EGFR Shows Synthetic Lethality
Structural analysis of the EGFR/HER3 heterodimer reveals the molecular basis for activating HER3 mutations | Science Signaling
mTOR-Rictor-EGFR axis in oncogenesis and diagnosis of glioblastoma multiforme | SpringerLink
EGFR signaling is critical for macrophage activation and function. (A)... | Download Scientific Diagram
Piezo1 activates noncanonical EGFR endocytosis and signaling | Science Advances
Expert consensus to optimize the management of older adult patients with advanced EGFR-mutated non-small cell lung cancer | Clinical and Translational Oncology
Identification and Optimization of Novel Cathepsin C Inhibitors Derived from EGFR Inhibitors | Journal of Medicinal Chemistry
EGFR inhibition led ROCK activation enhances desmosome assembly and cohesion in cardiomyocytes | bioRxiv
The EGFR-mTOR pathway. Schematic figure displaying the molecular... | Download Scientific Diagram
